Profilo
Steven J.
Favaloro is Chairman, President & Chief Executive Officer at Genezen Laboratories, Inc. since 2023.
Mr. Favaloro is Strategic Advisor at Kineticos Ventures LLC.
Mr. Favaloro is Executive Advisor at Ampersand Management LLC since 2023.
Formerly, Mr. Favaloro was Chief Financial Officer at Arbor Biotechnologies, Inc. from 2022 to 2023.
Mr. Favaloro was Chief Financial Officer at Arranta Bio Holdings LLC from 2019 to 2022.
Mr. Favaloro was Chief Financial Officer at Brammer Bio LLC from 2016 to 2019.
Mr. Favaloro completed undergraduate studies at Boston College in 2008.
Mr. Favaloro earned graduate degrees, including an MBA, from Wallace E Carroll School of Management in 2013.
Posizioni attive di Steven Favaloro
| Società | Posizione | Inizio |
|---|---|---|
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Operates as a cell and gene therapy contract development & manufacturing organization | Amministratore Delegato | 13/03/2023 |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Consulente / Consigliere | 01/03/2023 |
Kineticos Ventures LLC
Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of bio technology sectors. It provides financing for growth stage capital requirements. | Consulente / Consigliere | - |
Precedenti posizioni note di Steven Favaloro
| Società | Posizione | Fine |
|---|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Direttore Finanziario/CFO | 01/03/2023 |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Develops and manufactures biological drugs and therapies | Direttore Finanziario/CFO | 01/02/2022 |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore Finanziario/CFO | 01/09/2019 |
Formazione di Steven Favaloro
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Develops and manufactures biological drugs and therapies | Health Technology |
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Operates as a cell and gene therapy contract development & manufacturing organization | Health Technology |
Kineticos Ventures LLC
Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of bio technology sectors. It provides financing for growth stage capital requirements. | Finance |
















